- ASSISTANT PROFESSOR | Urology
- Hospital Affiliations
- Mount Sinai St. Luke's and Mount Sinai West
- Mount Sinai Beth Israel
- The Mount Sinai Hospital
Female Pelvic Medicine and Reconstructive Surgery
American Board of Urology
- Benign Prostatic Hyperplasia
- Extracorporeal Shock Wave Lithotripsy For Kidney Stones
- Flank pain
- Kidney Stones
- Lower urinary tract symptoms
- Neurogenic Bladder
- Photoselective vaporization of the prostate for BPH
- Prostate Biopsy
- Prostate-Specific Antigen (PSA) Test
- Reconstructive Surgery
- Transurethral Resection Of The Prostate
- Urethral Suspension
- Urethral Suspension-Sling Procedure
- Urinary Tract Infection
- Urinary urgency
- Vesicoureteral Reflux
MD, SUNY at Stony Brook School of Medicine
Internship, General Surgery
SUNY Downstate Medical Center
SUNY Downstate Medical Center - College of Medicine
Fellowship, Femal Pelvic Medicine and Reconstructive Surgery
Univ. of California, Los Angeles
Dr. Shah's clinical research is focused on the treatment of overactive bladder and pelvic organ prolapse (POP). An active clinical trial looking at long term outcomes with the use of biologic grafts as an alternative to vaginal mesh is currently in progress. Dr Shah is also interested in outpatient minimally invasive treatments for benign prostatic hyperplasia (BPH) using Bipolar Transurethral Resection of the Prostate and Laser Vaporization of Prostate. He and his team are also currently enrolling patients in a clinical trial for an outpatient, office-based procedure for the treatment of BPH.
Shah SM, Gaunay GS. Treatment options for intrinsic sphincter deficiency. Nature reviews. Urology 2012 Nov; 9(11).
Rutman MP, Deng DY, Shah SM, Raz S, Rodríguez LV. Spiral sling salvage anti-incontinence surgery in female patients with a nonfunctional urethra: technique and initial results. The Journal of urology 2006 May; 175(5).
Rodríguez LV, Bukkapatnam R, Shah SM, Raz S. Transvaginal paravaginal repair of high-grade cystocele central and lateral defects with concomitant suburethral sling: report of early results, outcomes, and patient satisfaction with a new technique. Urology 2005 Nov; 66(5 Suppl).
Physicians and scientists on the faculty of the Icahn School of Medicine at Mount Sinai often interact with pharmaceutical, device and biotechnology companies to improve patient care, develop new therapies and achieve scientific breakthroughs. In order to promote an ethical and transparent environment for conducting research, providing clinical care and teaching, Mount Sinai requires that salaried faculty inform the School of their relationships with such companies.
Below are financial relationships with industry reported by Dr. Shah during 2017 and/or 2018. Please note that this information may differ from information posted on corporate sites due to timing or classification differences.
Industry-Sponsored Lectures: MSSM faculty occasionally give lectures at events sponsored by industry, but only if the events are free of any marketing purpose
Mount Sinai's faculty policies relating to faculty collaboration with industry are posted on our website. Patients may wish to ask their physician about the activities they perform for companies.
Physicians who provide services at hospitals and facilities in the Mount Sinai Health System might not participate in the same health plans as those Mount Sinai hospitals and facilities (even if the physicians are employed or contracted by those hospitals or facilities).
Information regarding insurance participation and billing by this physician may be found on this page, and can also be obtained by contacting this provider directly. Because physicians insurance participation can change, the insurance information on this page may not always be up-to-date. Please contact this physician directly to obtain the most up-to-date insurance information.
Insurance and health plan networks that the various Mount Sinai Health System hospitals and facilities participate in can be found on the Mount Sinai Health System website.